| 13/12/22 | 15:45:01 | 13 Dec 2022 | | Successful completion of US$18.5m Equity Fundraise |
| 13/12/22 | 07:02:01 | 13 Dec 2022 | | Investor presentation |
| 13/12/22 | 07:01:01 | 13 Dec 2022 | | Placing & Subscription to raise approx. US$18m |
| 13/12/22 | 07:00:04 | 13 Dec 2022 | | Collaborative Sales Agreement signed with Viatris |
| 31/10/22 | 07:00:07 | 31 Oct 2022 | | Republic of Korea update |
| 27/10/22 | 07:00:03 | 27 Oct 2022 | | Shelf-life for Accrufer® extended to 48 months |
| 24/10/22 | 07:00:10 | 24 Oct 2022 | | Data presented at ACG Annual Scientific Meeting |
| 30/09/22 | 07:00:17 | 30 Sept 2022 | | Block Listing 6 Monthly Return |
| 14/09/22 | 14:17:41 | 14 Sept 2022 | | Holding(s) in Company |
| 08/09/22 | 07:00:06 | 8 Sept 2022 | | Half-year Report |
| 01/09/22 | 14:20:05 | 1 Sept 2022 | | Holding(s) in Company |
| 01/09/22 | 07:00:09 | 1 Sept 2022 | | Launch of new corporate brand and website |
| 31/08/22 | 14:00:06 | 31 Aug 2022 | | Total Voting Rights Update |
| 31/08/22 | 11:00:08 | 31 Aug 2022 | | Notice of Interim Results |
| 30/08/22 | 09:30:01 | 30 Aug 2022 | | Holding(s) in Company |
| 09/08/22 | 16:45:03 | 9 Aug 2022 | | Grant of share options |
| 01/08/22 | 07:00:11 | 1 Aug 2022 | | Completion of Loan Agreement & Partial Conversion |
| 27/07/22 | 16:20:04 | 27 Jul 2022 | | Results of 2022 General Meeting |
| 27/07/22 | 16:15:05 | 27 Jul 2022 | | Results of 2022 Annual General Meeting |
| 14/07/22 | 07:00:05 | 14 Jul 2022 | | New Drug Submission accepted by Health Canada |
| 08/07/22 | 07:00:06 | 8 Jul 2022 | | Notice of General Meeting |
| 30/06/22 | 16:41:30 | 30 Jun 2022 | | Second Price Monitoring Extn |
| 30/06/22 | 16:36:24 | 30 Jun 2022 | | Price Monitoring Extension |
| 30/06/22 | 14:06:17 | 30 Jun 2022 | | Second Price Monitoring Extn |
| 30/06/22 | 14:00:56 | 30 Jun 2022 | | Price Monitoring Extension |
| 30/06/22 | 11:05:50 | 30 Jun 2022 | | Second Price Monitoring Extn |
| 30/06/22 | 11:00:54 | 30 Jun 2022 | | Price Monitoring Extension |
| 30/06/22 | 09:05:31 | 30 Jun 2022 | | Second Price Monitoring Extn |
| 30/06/22 | 09:00:17 | 30 Jun 2022 | | Price Monitoring Extension |
| 30/06/22 | 07:01:03 | 30 Jun 2022 | | 2021 Annual Report and 2022 AGM Notice |
| 30/06/22 | 07:00:07 | 30 Jun 2022 | | Business Update, Final Results&Financing Agreement |
| 29/06/22 | 07:00:09 | 29 Jun 2022 | | Notice of Results |
| 28/06/22 | 16:40:46 | 28 Jun 2022 | | Second Price Monitoring Extn |
| 28/06/22 | 16:35:44 | 28 Jun 2022 | | Price Monitoring Extension |
| 28/06/22 | 14:05:43 | 28 Jun 2022 | | Second Price Monitoring Extn |
| 28/06/22 | 14:00:42 | 28 Jun 2022 | | Price Monitoring Extension |
| 29/04/22 | 07:00:02 | 29 Apr 2022 | | Total Voting Rights Update |
| 31/03/22 | 15:50:06 | 31 Mar 2022 | | Block Listing Application |
| 31/03/22 | 15:50:06 | 31 Mar 2022 | | Block Listing 6 Monthly Return |
| 21/03/22 | 07:00:08 | 21 Mar 2022 | | KYE Pharmaceuticals Files Accrufer® NDS in Canada |
| 25/02/22 | 07:00:09 | 25 Feb 2022 | | Investor Presentation |
| 23/02/22 | 14:06:15 | 23 Feb 2022 | | Second Price Monitoring Extn |
| 23/02/22 | 14:01:09 | 23 Feb 2022 | | Price Monitoring Extension |
| 23/02/22 | 11:05:51 | 23 Feb 2022 | | Second Price Monitoring Extn |
| 23/02/22 | 11:00:40 | 23 Feb 2022 | | Price Monitoring Extension |
| 18/02/22 | 14:06:01 | 18 Feb 2022 | | Second Price Monitoring Extn |
| 18/02/22 | 14:00:48 | 18 Feb 2022 | | Price Monitoring Extension |
| 17/02/22 | 09:05:58 | 17 Feb 2022 | | Second Price Monitoring Extn |
| 17/02/22 | 09:00:40 | 17 Feb 2022 | | Price Monitoring Extension |
| 17/02/22 | 07:00:08 | 17 Feb 2022 | | Full Year Trading Update |
